Proven Safe and Effective

The WATCHMAN™ LAAC Device offers a proven stroke risk reduction option for patients with non-valvular atrial fibrillation who are seeking an alternative to long-term warfarin therapy.

Safety Outcomes in PROTECT AF, CAP and PREVAIL

Safety outcomes in the PROTECT AF trial, CAP registry and PREVAIL trial demonstrated improvement in both implant success and complication rate1.